May 21, 2024 / 11:00AM GMT
Operator
Good day and welcome to the Q4 and FY24 earnings conference call of Eris Lifesciences Limited. We have with us today on the call, Mr. Amit Bakshi, Chairman and Managing Director, and Mr. V Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this call is being recorded.
I now hand the conference over to Mr. V. Krishna Kumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir. Please go ahead.
Krishnakumar Vaidyanathan - Eris Lifesciences Ltd - Chief Operating Officer, Executive Director
Good afternoon, and welcome to our quarter four and FY24 business update. So just before we get into the quarter. I think this is a good time to kind of recap the journey that we have been over the last 24 months or so. It's been nothing short of transformative as far as our business is concerned.
As far as the footprint is concerned, it began with the acquisition of Oaknet in May '22, followed by the acquisition of suite of brands from Glenmark and Dr. Reddy's later
Q4 2024 Eris Lifesciences Ltd Earnings Call Transcript
May 21, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers